Skip to main content

Foghorn Therapeutics Inc.

FHTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822462

No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Foghorn Therapeutics Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of FHTX: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders9082−8
Shares40.4M41.0M+544.2K (+1.3%)
Value$147.5M$192.5M+$45.0M (+30.5%)

New holders (8)

Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to FHTX in Q2 2025
InstitutionSharesValue% of portfolio
Cantor Fitzgerald, L. P.150,000$705.0K0.02%
Ameriprise Financial Inc112,237$527.5K0.00%
Jane Street Group, LLC21,622$101.6K0.00%
MetLife Investment Management21,603$101.5K0.00%
Price T Rowe Associates Inc14,247$67.0K0.00%
Voya Investment Management LLC10,160$47.8K0.00%
Advisor Group Holdings, Inc.1,001$4.71K0.00%
Essential Partners LLC5$240.00%

Sold out (16)

Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of FHTX in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Rockwood Wealth Management, LLC107,329$391.8K
Qube Research & Technologies Ltd51,098$186.5K
Squarepoint Ops LLC44,040$160.7K
Trexquant Investment LP35,585$129.9K
Brevan Howard Capital Management LP28,606$104.4K
Wingate Wealth Advisors, Inc.28,471$103.9K
Exchange Traded Concepts, LLC27,693$101.1K
HSBC Holdings PLC18,709$66.6K
Alta Wealth Advisors LLC15,032$54.9K
D. E. Shaw & Co., Inc.14,875$54.3K
Sherbrooke Park Advisers LLC13,075$47.7K
Corebridge Financial, Inc.12,373$45.2K
SG Americas Securities, LLC12,118$44.0K
Acadian Asset Management LLC9,495$34.0K
Washington Trust Co1,500$5.47K
GAMMA Investing LLC96$350